Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | CNR2 | P34972 | 2/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | PSMD10 | O75832 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.43 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8498573 | 0.95 | CA2 (0.51) | CA2SMN1; SMN2CNR2CYP2C9CYP2C19 | |
| SCHEMBL2567795 | 0.94 | ALDH1A1 (0.47) | CA2SMN1; SMN2CNR2CYP2C9CYP2C19 | |
| SCHEMBL18934371 | 0.94 | ALDH1A1 (0.47) | CA2SMN1; SMN2CNR2CYP2C9CYP2C19 | |
| SCHEMBL8499603 | 0.91 | CA2 (0.53) | CA2SMN1; SMN2CNR2CYP2C9CYP2C19 | |
| SCHEMBL27572259 | 0.91 | CA2 (0.59) | CA2SMN1; SMN2CNR2LMNATSHR | |
| SCHEMBL18926560 | 0.89 | GAA (0.50) | CA2SMN1; SMN2CNR2CYP2C9CYP2C19 | |
| SCHEMBL18926556 | 0.89 | CNR2 (0.48) | CA2SMN1; SMN2CNR2CYP2C9CYP2C19 | |
| SCHEMBL187914 | 0.87 | CA1 (0.47) | CA2SMN1; SMN2CYP2C9CYP2C19LMNA | |
| SCHEMBL8927880 | 0.87 | CA1 (0.47) | CA2SMN1; SMN2CYP2C9CYP2C19LMNA | |
| SCHEMBL4793354 | 0.87 | FKBP1A (0.52) | CA2SMN1; SMN2CNR2CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170158521-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2017-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170158521-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | CD14, ERG28, DAP3 | CA2 2868/4885SMN1; SMN2 4426/4885CNR2 4136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.